Prostate Screening in Patients With 46,XY Disorders of Sex Development-Is it Necessary?

Journal of Urology

Volumn 180, Issue 4, 2008, Pages 1422-1426

  Salmasi, Amirali Hassanzadeh ^a   Wisniewski, Amy B ^a   Novak, Tomas E ^a   Gearhart, John P ^a   Migeon, Claude J ^a   Lakshmanan, Yegappan ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

digital rectal examination; hermaphroditism; mass screening; prostate; prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; BLOOD SAMPLING; CANCER RISK; COMPLETE ANDROGEN INSENSITIVITY SYNDROME; DIGITAL RECTAL EXAMINATION; FOLLOW UP; GONADAL DYSGENESIS; HERMAPHRODITISM; HUMAN; KARYOTYPE 46,XY; MALE; MALE PSEUDOHERMAPHRODITISM; MICROPENIS; PARTIAL ANDROGEN INSENSITIVITY SYNDROME; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCREENING TEST; SEX DIFFERENTIATION DISORDER; SEXUAL DEVELOPMENT;

ADULT; AGE FACTORS; COHORT STUDIES; DIGITAL RECTAL EXAMINATION; FEMALE; FOLLOW-UP STUDIES; GONADAL DYSGENESIS, 46,XY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PSEUDOHERMAPHRODITISM; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; TESTOSTERONE;

EID: 50949108942     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.06.043     Document Type: Article

References (20)

1. Avila D.M., Zoppi S., and McPhaul M.J. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer. J Steroid Biochem Mol Biol 76 (2001) 135
2. Brinkmann A.O. Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179 (2001) 105
3. Denis L.J., and Griffiths K. Endocrine treatment in prostate cancer. Semin Surg Oncol 18 (2000) 52
4. Wisniewski A.B., Migeon C.J., Meyer-Bahlburg H.F., Gearhart J.P., Berkovitz G.D., Brown T.R., et al. Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab 85 (2000) 2664
5. Migeon C.J., Wisniewski A.B., Gearhart J.P., Meyer-Bahlburg H.F., Rock J.A., Brown T.R., et al. Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics 110 (2002) e31
6. Aaronson I.A. Micropenis: medical and surgical implications. J Urol 152 (1994) 4
7. Lee P.A., Mazur T., Danish R., Amrhein J., Blizzard R.M., Money J., et al. Micropenis. I. Criteria, etiologies and classification. Johns Hopkins Med J 146 (1980) 156
8. Berkovitz G.D., Fechner P.Y., Zacur H.W., Rock J.A., Snyder III H.M., Migeon C.J., et al. Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: its relevance to the understanding of sex differentiation. Medicine (Baltimore) 70 (1991) 375
9. Roy A.K., Lavrovsky Y., Song C.S., Chen S., Jung M.H., Velu N.K., et al. Regulation of androgen action. Vitam Horm 55 (1999) 309
10. Noble R.L. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37 (1977) 1929
11. Pollard M., Luckert P.H., and Schmidt M.A. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate 3 (1982) 563
12. Brinkmann L., Schuetzmann K., and Richter-Appelt H. Gender assignment and medical history of individuals with different forms of intersexuality: evaluation of medical records and the patients' perspective. J Sex Med 4 (2007) 964
13. Shi X.B., Xue L., Tepper C.G., Gandour-Edwards R., Ghosh P., Kung H.J., et al. The oncogenic potential of a prostate cancer-derived androgen receptor mutant. Prostate 67 (2007) 591
14. Gottlieb B., Beitel L.K., Wu J.H., and Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23 (2004) 527
15. Jenster G., van der Korput H.A., van Vroonhoven C., van der Kwast T.H., Trapman J., and Brinkmann A.O. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 5 (1991) 1396
16. Andrew S.E., Goldberg Y.P., and Hayden M.R. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 6 (1997) 2005
17. Gottlieb B., Beitel L.K., Lumbroso R., Pinsky L., and Trifiro M. Update of the androgen receptor gene mutations database. Hum Mutat 14 (1999) 103
18. Smith R.A., Cokkinides V., and Eyre H.J. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 57 (2007) 90
19. Whittemore A.S., Cirillo P.M., Feldman D., and Cohn B.A. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of black and white Americans. J Urol 174 (2005) 872
20. Preston D.M., Levin L.I., Jacobson D.J., Jacobsen S.J., Rubertone M., Holmes E., et al. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology 56 (2000) 812